Acupuncture and magnetic stimulation to help movement after stroke
Tests electrical acupuncture with magnetic brain stimulation in adults recovering from stroke.
Plain-language title generated from the registry record
Registry title: Electroacupuncture and rTMS for Post-Stroke Motor Recovery
Key facts
- Where
- Fuzhou and Wenzhou, ChinaSee the 3 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 75 years old?
Source: NCT07113990, who can take part
Where in China
- Fujian Provincial People's HospitalFuzhou, ChinaNot yet recruiting
- Fuzhou University Affiliated Provincial HospitalFuzhou, ChinaTaking people
- Wenzhou Hospital of Traditional Chinese MedicineWenzhou, ChinaNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Jing Tao
- Trial code
- NCT07113990
- Record updated
- 3 November 2026
- Original description
This study aims to evaluate the combined efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) and Electroacupuncture (EA) in improving motor function recovery post-stroke, compared to rTMS combined with sham EA. Participants will receive either active EA or sham EA alongside standard rTMS treatment. Outcomes will be assessed using standardized clinical scales and neuroimaging techniques to explore underlying neuroplasticity mechanisms.Read full original descriptionShow less
Efficacy and Safety of Electroacupuncture Combined With rTMS on Motor Function Recovery After Stroke: A Multi-center Randomized Controlled Clinical Study
This study aims to evaluate the combined efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) and Electroacupuncture (EA) in improving motor function recovery post-stroke, compared to rTMS combined with sham EA. Participants will receive either active EA or sham EA alongside standard rTMS treatment. Outcomes will be assessed using standardized clinical scales and neuroimaging techniques to explore underlying neuroplasticity mechanisms.
Inclusion: Diagnosed with stroke confirmed by neuroimaging (CT/MRI); First-ever stroke, unilateral hemispheric lesion, related to motor dysfunction; Age between 40 and 75 years; Duration from stroke onset between 2 weeks and 6 months; Brunnstrom stage II-IV; Right-handed; Able to understand instructions and voluntarily provide written informed consent.
Exclusion: Presence of metallic implants or contraindications for MRI; Pregnancy, breastfeeding, or concurrent participation in other clinical trials affecting outcomes; History of epilepsy or familial epilepsy; Severe aphasia or cognitive impairment (MoCA < 18); Severe systemic complications (e.g., severe organ dysfunction, deep vein thrombosis); Motor dysfunction due to non-vascular causes (e.g., tumor, trauma); Severe anxiety (HAMA > 7) or depression (HAMD > 8); Severe spasticity (modified Ashworth ≥ 2); Fear or intolerance of TMS or electroacupuncture.